Organization: Health Canada
Year: 2023
Month: January
Request Number: A-2022-001002
Request Summary: Adverse Drug Reaction (ADR) for MEZAVANT. Report number: E2B_05680477. ADRs for Mesalazine. Report numbers: 001006029, 001006464, E2B_05628348, E2B_05643268. ADRs for VYVANSE. Report numbers: 001005158, E2B_05661529, 001005967. ADRs for GAMMAGARD LIQUID. Report numbers: 001011490, 001008161.
Disposition: Disclosed in part
Number of pages: 197